Uncategorized

Immutep (ASX:IMM) has released its annual report, detailing significant progress over the past year with its lead immunotherapy candidate eftilagimod alpha (efti). This drug is designed to activate the body’s immune system to better recognise and attack cancer cells. It targets LAG-3, a protein that plays a key role in regulating immune responses. Specifically, efti […]

Medical technology company ImpediMed (ASX:IPD) continues to make strides with its SOZO® Digital Health Platform, reporting significant progress in its Q1 FY25 results. The company’s pipeline for SOZO units increased by 34%, with 28 units sold in the US, a notable rise from the previous quarter’s 23 units. SOZO, which uses bioimpedance spectroscopy (BIS), is

Next Science Limited (ASX:NXS), a Sydney-based medical technology company, has reported a 7% dip in product sales for the third quarter of FY24, generating US$4.7 million. The decline follows the restructuring of its Durable Medical Equipment (DME) sales channel. Despite these challenges, the company remains optimistic about future growth, with total year-to-date sales up 5%.

Praemium Limited (ASX:PPS) reported a robust start to FY25, with total Funds Under Administration (FUA) increasing by 33% to $59.4 billion as of 30 September 2024, outpacing market expectations. This included a 30% jump in platform FUA to $29.0 billion. Praemium’s Separately Managed Accounts (SMA) continued to be a key driver, contributing $11.9 billion of

Transurban (ASX:TCL) reported a 1.1% rise in average daily traffic (ADT) for the September 2024 quarter, reaching 2.5 million daily trips across its assets. While Sydney and Brisbane saw increases of 1.9% and 1.3%, respectively, Melbourne experienced a 1% decline due to ongoing construction projects such as the West Gate Tunnel and lower container volumes

Mirvac Group (ASX:MGR) has made a strong start to FY25, driven by its residential and industrial segments and a $0.5 billion non-core asset sales program. In its Q1 FY25 operational update, Mirvac confirmed it finalised the sale of its Melbourne property at 367 Collins Street and entered into a $50 million deal for the sale

Viva Energy (ASX:VEA) posted solid sales growth for the third quarter of 2024, with group sales volumes rising by 3% year-on-year to 4.2 billion litres. This was driven by a 3.7% increase in Commercial & Industrial (C&I) sales, bolstered by the company’s Defence, Aviation, and Liberty Rural Group sectors. Convenience & Mobility (C&M) fuel sales

Vinyl Group (ASX:VNL) has announced a major commercial agreement with Songtradr, the world’s largest B2B music licensing platform. This partnership will allow Vinyl Group to manage and sell advertising across Songtradr’s digital portfolio, expanding the scale of Vinyl’s advertising business by up to 20 times. Songtradr’s platforms attract over 20 million unique viewers each month,

The Australian sharemarket declined from near record highs on Tuesday amid a broad sell-off, mirroring a pullback on Wall Street as investors opted to take some profits. At 11:35am, the S&P/ASX 200 is 1.13 per cent lower at 8,250.10. The SPI futures are pointing to a fall of 108 points. Best and worst performers All